Senior Director, Oncology R&D - Clinical Scientist

Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

Job Summary:

Oversees a number of trials of a multinational program in a specific indication, i.e., multiple multinational phase II/III clinical trials; Reviews regulatory documents from cross functional, holistic perspective; Represents clinical function at meetings with health authorities; Oversees management and performance of CRO. Occasional interactions with CRO senior leadership as needed; Participates in creation of developmental and regulatory strategy in collaboration with Regulatory Affairs; Drafts clinical development plans, protocol profiles and sections of key submission documents; Point of contact for interactions with regulatory-agency clinical reviewing divisions on clinical matters; Supports marketing in developing a commercial strategy include biomarker strategy; Represents Clinical Development as Global Clinical Lead or as Team Leader (ITL-ISTL)

Responsibilities:

Study Strategy: For Phase 2 and Phase 3 registrational studies: Provides the strategic direction to BD&O for EDC, edit checks, data quality listings, SAP, DM plan, Reviews patient population and protocol compliance for consistency with study strategy, Develops biomarker strategy in collaboration with Translational Medicine, Collaborates with external KEEs to refine study plans; Prepares and participate in regulatory agency meetings, if applicable; Defines study strategy across clinical trials within an indication or project; Attends EOP2 meeting and represents clinical/TMCP

Study Planning and Execution: Clinical Study Lead (CSL) for large Phase 3 registrational study(ies); Develop prospective contingency plans for management of key risks in a large study or project; Clearly define study priorities and high level execution plan, communicate to members of study team within sponsor, CRO and vendors; Ensure clear and effective lines of communication and decision-making process cross-functionally and cross-regionally; Facilitate team coordination

Study outputs: For Phase 3 studies: Drafts responses to IRBs and HA, Collaborates with Translational Medicine to ensure appropriate biomarker, PK / PD measurements, Reviews emerging clinical data regularly, Leads dose-escalation meetings, Performs quality assessment with delivery lead e.g. review TLG before DBL, and quality check of data, Works with BD&O to ensure SAP updates; Interact with Key External Experts (KEEs) to validate interpretation of study results; Present results to regulatory agencies during pre-submission meetings; Interpret study results in context of other studies in the project and other drugs used for the indication

External collaboration: Develops and leads Ad-Board with top tier KOLs for project level strategic advice; Develops and leads steering committee for Phase 3 registrational study; Consults with KOLS for advice on complex development or safety issues

Scientific, Program related: Integrated Study Team (IST) representative or IST leader on study team; Responsible before senior management for the creation and execution of development strategies for program/s under IST; Obtains cross-functional alignment ; Leads development and execution of Product Development Plan and clinical development strategy; Leads Integrated Project Team (IPT) working closely with Global Project Management to ensure cross-functional coordination and focus to agreed strategy; Coordinates clinical activities across the project; Represents IPT to Sr. Management

Additional non-study related activities: Provides input on KEE selection for Therapeutic Area; Reviews content to be shared with KEEs; Frequent involvement in Business Development activities for late stage compounds; Involvement with in-licensing and acquisitions on due diligence activities; Major contributor to portfolio decisions

Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education/Experience:

Master's degree; PharmD, PhD, or equivalent; Postgraduate training in TA or related specialty, or equivalent, desirable

9+ years with PharmD, PhD and relevant clinical experience
12+ years with Master's degree and relevant clinical experience

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.

Job Title
Senior Director, Oncology R&D - Clinical Scientist

City
Basking Ridge

Functional Area
Global Oncology R&D

State
New Jersey